On the 24th of June 2024, Cell Tissue Technology Sdn. Bhd. achieved a groundbreaking milestone by being celebrated as a “Soonicorn” by the Ministry of Science, Technology, and Innovation (MOSTI). This prestigious recognition cements Cell Tissue as one of Malaysia’s top startups destined for unicorn status, with an impressive valuation nearing US$1 billion. As one of the select 22% Bumiputera-owned companies, this accolade underscores our dominance in healthcare and beauty innovation.
Being honored with the Soonicorn title is not just an achievement; it’s a powerful validation of our relentless pursuit of excellence and innovation in biotechnology. It signifies the government’s and industry’s acknowledgment of our pivotal role in driving Malaysia’s economic and technological future. Discussed in Parliament, this recognition places Cell Tissue at the forefront of the nation’s prosperity.
For Malaysians, this is a moment of immense pride. It proves that our country can produce world-class innovations and lead in the global biotech arena. For Malaysia, it signifies a bold step towards becoming a global leader in healthcare and beauty technology, showcasing our capability to nurture and elevate local companies to international prominence.
Cell Tissue Technology’s recognition as a Soonicorn is a testament to our groundbreaking work and visionary leadership. It’s a bold statement that Malaysian innovation is not just competent but exceptional, poised to revolutionize the industry on a global scale.
